\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ surgery\\ and\\ radiation\\ therapy\ \(3\)\
\-\ \\â\\€\\¢\\ intradural\\ extramedullary\\ mass\\ at\\ l1\\-2\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ enhances\\ following\\ contrast\\ administration\ \(0\)\
\-\ diffuse\\ large\\ cell\\ lymphoma\\ arising\\ in\\ angiomatous\\ meningioma\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ schwannoma\\ or\\ neurofibroma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ lesion\ \(0\)\
\-\ 65\\ year\\ old\\ man\\ presents\\ with\\ bilateral\\ leg\\ weakness\ \(1\)\
\-\ this\\ is\\ a\\ very\\ unusual\\ case\\.\\ \\ the\\ patient\\ has\\ a\\ combined\\ tumor\\ with\\ two\\ distinct\\ cell\\ types\\:\\ both\\ lymphoma\\ and\\ meningioma\\.\ \(0\)\
\-\ the\\ diagnosis\\ was\\ based\\ on\\ microscopic\\ examination\\ as\\ well\\ as\\ multiple\\ immunostains\\ and\\ immunohistochemical\\ tests\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ meningioma\\:\\ 0\\.35237434163661363\ \(0\)\
\-\ angiomatous\\:\\ 0\\.2316342483324804\ \(0\)\
\-\ immunostains\\:\\ 0\\.2316342483324804\ \(0\)\
\-\ immunohistochemical\\:\\ 0\\.21258696731105312\ \(0\)\
\-\ lymphoma\\:\\ 0\\.1867117564910967\ \(0\)\
\-\ cell\\:\\ 0\\.179339416075457\ \(0\)\
\-\ extramedullary\\:\\ 0\\.17626588625938078\ \(0\)\
\-\ microscopic\\:\\ 0\\.17626588625938078\ \(0\)\
\-\ intradural\\:\\ 0\\.17449240526819854\ \(0\)\
\-\ distinct\\:\\ 0\\.1663732206958579\ \(0\)\
\-\ combined\\:\\ 0\\.15544512424677123\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.15501907822618352\ \(0\)\
\-\ tests\\:\\ 0\\.1500089879799631\ \(0\)\
\-\ types\\:\\ 0\\.1457730170337321\ \(0\)\
\-\ unusual\\:\\ 0\\.14056234620444513\ \(0\)\
\-\ enhances\\:\\ 0\\.1381713242165262\ \(0\)\
\-\ schwannoma\\:\\ 0\\.1343307473993924\ \(0\)\
\-\ 65\\:\\ 0\\.13413233918818926\ \(0\)\
\-\ ependymoma\\:\\ 0\\.13240832610932557\ \(0\)\
\-\ as\\:\\ 0\\.12594616365754227\ \(0\)\
\-\ administration\\:\\ 0\\.12482985206652349\ \(0\)\
\-\ arising\\:\\ 0\\.1245494474102682\ \(0\)\
\-\ mass\\:\\ 0\\.11975061578518391\ \(0\)\
\-\ leg\\:\\ 0\\.11833402605383757\ \(0\)\
\-\ weakness\\:\\ 0\\.11440169817359525\ \(0\)\
\-\ based\\:\\ 0\\.11354734693961108\ \(0\)\
\-\ very\\:\\ 0\\.11244802363265077\ \(0\)\
\-\ available\\:\\ 0\\.10635211304644633\ \(0\)\
\-\ radiation\\:\\ 0\\.10387729403209917\ \(0\)\
\-\ examination\\:\\ 0\\.10030671680322524\ \(0\)\
\-\ diffuse\\:\\ 0\\.09830328118248936\ \(0\)\
\-\ and\\:\\ 0\\.09717301578967392\ \(0\)\
\-\ following\\:\\ 0\\.09403665834476786\ \(0\)\
\-\ two\\:\\ 0\\.09308821946182518\ \(0\)\
\-\ therapy\\:\\ 0\\.09006453405225198\ \(0\)\
\-\ both\\:\\ 0\\.0874129479069334\ \(0\)\
\-\ metastatic\\:\\ 0\\.08597095858411138\ \(0\)\
\-\ surgery\\:\\ 0\\.08427682665194809\ \(0\)\
\-\ bilateral\\:\\ 0\\.0842446304937576\ \(0\)\
\-\ man\\:\\ 0\\.0829867716439634\ \(0\)\
\-\ tumor\\:\\ 0\\.08199070346483445\ \(0\)\
\-\ diagnosis\\:\\ 0\\.08125943578179794\ \(0\)\
\-\ case\\:\\ 0\\.07875080069773242\ \(0\)\
\-\ large\\:\\ 0\\.07854083277744586\ \(0\)\
\-\ multiple\\:\\ 0\\.0766711072514143\ \(0\)\
\-\ contrast\\:\\ 0\\.07616288688678631\ \(0\)\
\-\ well\\:\\ 0\\.07590038068158189\ \(0\)\
\-\ presents\\:\\ 0\\.07540609088743781\ \(0\)\
\-\ lesion\\:\\ 0\\.07515068254551534\ \(0\)\
\-\ has\\:\\ 0\\.0716000193822075\ \(0\)\
\-\ the\\:\\ 0\\.06255564636208481\ \(0\)\
\-\ not\\:\\ 0\\.061882196940072146\ \(0\)\
\-\ with\\:\\ 0\\.06138823677405434\ \(0\)\
\-\ at\\:\\ 0\\.05920744070321939\ \(0\)\
\-\ was\\:\\ 0\\.054629832329092\ \(0\)\
\-\ or\\:\\ 0\\.05453143765032246\ \(0\)\
\-\ this\\:\\ 0\\.053863015558476404\ \(0\)\
\-\ patient\\:\\ 0\\.05098375097334671\ \(0\)\
\-\ year\\:\\ 0\\.04830806451095406\ \(0\)\
\-\ on\\:\\ 0\\.04734197521350723\ \(0\)\
\-\ old\\:\\ 0\\.04639246418203538\ \(0\)\
\-\ is\\:\\ 0\\.04292776394260748\ \(0\)\
\-\ in\\:\\ 0\\.03899495911748274\ \(0\)\
